Key statistics
On Friday, Adicet Bio Inc (1IJA:BER) closed at 1.21, 27.13% above the 52 week low of 0.951 set on Jul 08, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.23 |
---|---|
High | 1.26 |
Low | 1.21 |
Bid | 1.14 |
Offer | 1.29 |
Previous close | 1.25 |
Average volume | 60.50 |
---|---|
Shares outstanding | 82.40m |
Free float | 81.09m |
P/E (TTM) | -- |
Market cap | 107.95m USD |
EPS (TTM) | -1.70 USD |
Data delayed at least 15 minutes, as of Nov 08 2024 20:52 GMT.
More ▼
Press releases
- Adicet Reports Third Quarter 2024 Financial Results and Provides Business Updates
- Adicet Bio to Present at the American College of Rheumatology (ACR) Convergence 2024
- Adicet Bio to Participate in Upcoming Investor Conferences
- Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- Adicet Bio Announces FDA Clearance of IND Amendment to Evaluate ADI-001 in Idiopathic Inflammatory Myopathy and Stiff Person Syndrome
- Adicet Bio to Present at the American Society of Gene & Cell Therapy’s (ASGCT) 2024 Advancing Gene + Cell Therapies for Cancer Conference
- Adicet Opens Enrollment for ADI-001 Phase 1 Clinical Trial in Autoimmune Diseases
- ADI-001 Clinical Biomarker Data Demonstrate Robust Tissue Trafficking and Complete B Cell Depletion in Secondary Lymphoid Tissue
- Adicet Bio to Present at the H.C. Wainwright 26th Annual Global Investment Conference
- Adicet Bio Appoints Lloyd Klickstein, M.D., Ph.D. to the Board of Directors
More ▼